Evidence for autoimmunity to heart-specific antigens in patients with Emery-Dreifuss muscular dystrophy

Acta Myologica

Volumn 25, Issue 2, 2006, Pages 68-72

  Niebroj Dobosz, Irena ^a   Dorobek, M ^a   Marchel, M ^b   Hausmanowa Petrusewicz, I ^a  

^a MOSSAKOWSKI MEDICAL RESEARCH CENTRE   (Poland)

^b MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Autoimmunity; Emery Dreifuss dystrophy; Heart proteins

Indexed keywords

ACTIN ANTIBODY; AUTOANTIBODY; HEART ANTIBODY; IMMUNOGLOBULIN G; MUSCLE PROTEIN; PROTEIN ANTIBODY; TROPOMYOSIN ANTIBODY; TROPONIN I ANTIBODY; UNCLASSIFIED DRUG;

ADULT; ANTIGEN SPECIFICITY; ARTICLE; AUTOIMMUNITY; CLINICAL ARTICLE; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; EMERY DREIFUSS MUSCULAR DYSTROPHY; HEART VENTRICLE WALL; HUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; WESTERN BLOTTING;

ADOLESCENT; ADULT; AUTOANTIBODIES; AUTOIMMUNITY; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHILD; FEMALE; HUMANS; MALE; MUSCLE PROTEINS; MUSCULAR DYSTROPHY, EMERY-DREIFUSS; MYOCARDIUM; REPRODUCIBILITY OF RESULTS;

EID: 33947369867     PISSN: 11282460     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Latif N, Baker CS, Dunn MJ, et al. Frequency and specificity of antiheart antibodies in patients with dilated cardiomyopathy detected using SDS- PAGE and Western blotting. J Am Coll Cardiol 1993;22:1378-84.
2. Limas CJ, Goldenberg IF, Limas C. Autoantibodies against β-adrenoceptors in human idiopathic dilated cardiomyopathy. Cir Res 1989;64:97-103.
3. Klein R, Maisch B, Kochsiek K, et al. Demonstration of organ-specific antibodies against heart mitochondria (anti-M7) in sera from patients with some forms of heart disease. Clin Exp Immunol 1984;58:283-92.
4. Schultheiss HP, Bolte HD. Immunological analysis of autoantibodies against the adenine nucleotide translocator in dilated cardiomyopathy. J Mol Cell Cardiol 1985;17:603-17.
5. Schultheiss HP, Klingenberg M. Immunochemical characterization of the nucleotide translocator: organ and conformation specificity. Eur J Biochem 1984;143:599-605.
6. Schultheiss HP, Schulze K, Kuhl U, et al. The ADP/ATP carrier as a mitochondrial autoantigen: facts and perspectives. Ann NY Acad Sci 1986;488:44-63.
7. Caforio ALP, Grazzini M, Mann JM, et al. Identification of α- and β-cardiac myosin heavy chain isoforms as major autoantigens in dilated cardiomyopathy. Circulation 1992;85:1734-42.
8. Caforio ALP, Goldman JH, Haven AJ, et al. Evidence for autoimmunity to myosin and other heart-specific autoantigens in patients with dilated cardiomyopathy and their relatives. Int J Cardiol 1996;54:157-63.
9. Caforio AL, Mahon NJ, Mckenna WJ. Cardiac autoantibodies to myosin and other heart-specific autoantigens in myocarditis and dilated cardiomyopathy. Autoimmunity 2001;34:199-204.
10. Peterson GL. A simplification of the protein assay method of Lowry et al. which is more generally applicable. Anal Biochem 1977;83:346-56.
11. Laemmli UH. Cleavage of structural proteins during assembly of the head of bacteriophage T4. Nature 1967;227:680-5.
12. Lauer B, Padberg K, Schultheiss HP, et al. Autoantibodies against cardiac myosin in patients with myocarditis and dilated cardiomyopathy (in German). Z Kardiol 1995;84:301-10.
13. Caforio AL, Goldman JH, Haven AJ, et al. Circulating cardiac-specific autoantibodies as markers of autoimmunity in clinical and biopsy-proven myocarditis. The Myocarditis Treatment Trial Investigators. Eur Heart J 1997;18:270-5.
14. Melguizo C, Prados J, Velez C, et al. Clinical significance of antiheart antibodies after myocardial infarction. Jpn Heart J 1997;38:779-86.
15. Latif N, Taylor PM, Khan MA, et al. The expression of heat shock protein 60 in patients with dilated cardiomyopathy. Basic Res Cardiol 1999;94:112-9.
16. Fukuta S, Yoshinaga T, Yamakawa K, et al. Dilated cardiomyopathy with special reference to humoral immunity. Jpn Circ J 1992;56:1073-80.
17. Lauer B, Schannwell M, Kuhl U, et al. Antimyosin autoantibodies are associated with deterioration of systolic and diastolic left ventricular function in patients with chronic myocarditis. J Am Coll Cardiol 2000;35:11-8.
18. Goldman JH, Keeling PJ, Warraich RS, et al. Autoimmunity to alpha myosin in a subset of patients with idiopathic dilated cardiomyopathy. Br Heart J 1995;74:598-603.
19. Stefan J. Heart antibodies in sudden death (in Czech). Soud Lek 1982;27:33-8.
20. Caforio AL, Goldman JH, Baig MK, et al. Cardiac autoantibodies in dilated cardiomyopathy become undetectable with disease progression. Heart 1997;77:62-7.
21. Caforio AL, Goldman JH, Baig MK, et al. Organ-specific cardiac autoantibodies in dilated cardiomyopathy - an update. Eur Heart J 1995;16:68-70.
22. Muntoni F, Di Lenarda A, Porcu M, et al. Dystrophin gene abnormalities in two patients with idiopathic dilated cardiomyopathy. Heart 1997;78:608-12.
23. Brodsky GL, Muntoni F, Miocic S, et al. Lamin A/C gene mutation associated with dilated cardiomyopathy with variable skeletal muscle involvement. Circulation 2000;101:473-6.
24. Taylor MR, Fain PR, Sinagra G, et al. Familial Dilated Cardiomyopathy Registry Research Group. Natural history of dilated cardiomyopathy due to lamin A/C gene mutations. J Am Coll Cardiol 2003;41:771-80.
25. Funakoshi M, Tsuchiya Y, Arahata K. Emerin and cardiomyopathy in Emery-Dreifuss muscular dystrophy. Neuromusc Disord 1999;9:108-14.
26. Hara H, Nagata H, Mawatari S, et al. Emery-Dreifuss muscular dystrophy. An autopsy case. J Neurol Sci 1987;79:23-31.
27. Yoshioka M, Saida K, Itagaki Y, et al. Follow up study of cardiac involvement in Emery-Dreifuss muscular dystrophy. Arch Dis Child 1989;64:713-15.
28. Hossein-Nia M, Baig K, Goldman JH, et al. Creatine kinase isoforms as circulating markers of deterioration in idiopathic dilated cardiomyopathy. Clin Cardiol 1997;20:55-60.
29. Lowry PJ, Thompson RA, Littler WA. Humoral immunity in cardiomyopathy. Br Heart J 1983;50:390-4.
30. Smith SC, Allen PM. Myosin-induced myocarditis is a T cell-mediated disease. J Immunol 1991;147:2141-7.
31. Schultheiss HP, Kuhl U, Janda I, et al. Antibody mediated enhancement of calcium permeability in cardiac myocytes. J Exp Med 1988;168:2105-19.
32. Schulze K, Becker BF, Schultheiss HP. Antibodies to the ADP/ATP carrier, an autoantibody in myocarditis and dilated cardiomyopathy, penetrate into myocardial cells and disturb energy metabolism in vivo. Cir Res 1989;64:179-92.
33. Schultze K, Becker BF, Schauer K, et al. Antibodies to the ADP/ATP carrier - an autoantigen in myocarditis and dilated cardiomyopathy - impair cardiac function. Circulation 1990;81:959-69.